Group A, B, C, and G Lancefield Antigen Biosynthesis is Initiated by a Conserved α-d-GlcNAc-β-1,4-l-rhamnosyltransferase
Overview
Authors
Affiliations
Group A carbohydrate (GAC) is a bacterial peptidoglycan-anchored surface rhamnose polysaccharide (RhaPS) that is essential for growth of and contributes to its ability to infect the human host. In this study, using molecular and synthetic biology approaches, biochemistry, radiolabeling techniques, and NMR and MS analyses, we examined the role of GacB, encoded in the GAC gene cluster, in the GAC biosynthesis pathway. We demonstrate that GacB is the first characterized α-d-GlcNAc-β-1,4-l-rhamnosyltransferase that synthesizes the committed step in the biosynthesis of the GAC virulence determinant. Importantly, the substitution of with the homologous gene from (Group B ), subsp. (Group C ), subsp. (Group G ), or complemented the GAC biosynthesis pathway. These results, combined with those from extensive studies, reveal a common phylogenetic origin of the genes required for this priming step in >40 pathogenic species of the genus, including members from the Lancefield Groups B, C, D, E, G, and H. Importantly, this priming step appears to be unique to streptococcal ABC transporter-dependent RhaPS biosynthesis, whereas the Wzx/Wzy-dependent streptococcal capsular polysaccharide pathways instead require an α-d-Glc-β-1,4-l-rhamnosyltransferase. The insights into the RhaPS priming step obtained here open the door to targeting the early steps of the group carbohydrate biosynthesis pathways in species of the genus of high clinical and veterinary importance.
Ambari A, Qhabibi F, Desandri D, Dwiputra B, Baravia P, Makes I F1000Res. 2025; 13:132.
PMID: 39959434 PMC: 11829149. DOI: 10.12688/f1000research.144903.3.
Structure and mechanism of biosynthesis of Streptococcus mutans cell wall polysaccharide.
Rush J, Zamakhaeva S, Murner N, Deng P, Morris A, Kenner C Nat Commun. 2025; 16(1):954.
PMID: 39843487 PMC: 11754754. DOI: 10.1038/s41467-025-56205-1.
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines.
Ajay Castro S, Passmore I, Ndeh D, Shaw H, Ruda A, Burns K NPJ Vaccines. 2025; 10(1):16.
PMID: 39843476 PMC: 11754613. DOI: 10.1038/s41541-025-01068-2.
New J, Fucile C, Callahan A, Burke J, Davis R, Duck W bioRxiv. 2024; .
PMID: 39464096 PMC: 11507706. DOI: 10.1101/2024.10.15.618486.
subsp. infection and its intersection with .
Xie O, Davies M, Tong S Clin Microbiol Rev. 2024; 37(3):e0017523.
PMID: 38856686 PMC: 11392527. DOI: 10.1128/cmr.00175-23.